99% Purity Peptides Retatrutide Epithalon Tirzepatide Cagrilintide Kpv Thymosin Alpha-1 CAS307297-39-8
TDS 53 Inquiries
307297-39-8
Pharmaceutical Grade
99%
GUANGZHOU
APKX
10 mg/vial 50mg*10vials
2026-12-16
peptides
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceEpitalon is an anti-aging agent and a telomerase activator. Epitalon has an inhibitory effect of the on the development of spontaneous tumors in mice, has geroprotective actions and intranasal administration increases neuronal activity. Epitalon can be used for cancer, old age and Retinitis Pigmentosa[1].Certificates
-
TDS
Basic Info-
Product Name:
Epitalon
Other Name:AE-0 peptide;Ala-Glu-Asp-Gly;alanyl-glutamyl-aspartyl-glycine;epitalon;epithalon;epithalone;307297-39-8;UNII-O65P17785G
CAS No.:307297-39-8
Molecular Formula:C14H22N4O9
InChIKeys:HGHOBRRUMWJWCU-FXQIFTODSA-N
Molecular Weight:390.346
Exact Mass:390.138672
Categories:
Characteristics-
PSA:
225
XLogP3:-2.02
Density:1.5±0.1 g/cm3
Boiling Point:959.8±65.0 °C at 760 mmHg
Flash Point:534.3±34.3 °C
Refractive Index:1.559
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptides
-
Location:
Room 3043, 3rd Floor, Building 15, No. 185 Xinda Road, Wanghailou Street, Hebei District, Tianjin
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
11-50
-
Year of Establishment:
2025
-
Certifications:
.,证书
-
-
Inquiry History53 Inquiries
Country Product Purchase Quantity Date Posted
United States
N-Acetyl Epitalon Amidate CAS 307297-39-8 Epitalon 99% White Powder 99% N-Acetyl Epitalon Amidate
1 Oct 4, 2023
United States
N-Acetyl Epitalon Amidate CAS 307297-39-8 Epitalon 99% White Powder 99% N-Acetyl Epitalon Amidate
1 G Oct 7, 2023
United States
Epitalon, NAD+, DSIP, 5-Amino-1MQ, PEG-MGF
1 May 9, 2026
United States
epithalon
10 MG Jun 3, 2026
United States
Epitalon
10 MT May 14, 2026
United Kingdom
Epitalon
50 MT Apr 22, 2026
Australia
Epithalon
2 G Apr 3, 2026
United States
Epithalon
500 MG Mar 25, 2026
Australia
Epithalon
30 MG Mar 19, 2026
United Kingdom
Epitalon
200 MG Mar 18, 2026
United States
Epitalon
50 MT Mar 16, 2026
United States
Epitalon
1 PCS Mar 10, 2026
India
Epitalon
1 KG Feb 26, 2026
United States
Epitalon (CAS 307297-39-8) and Pinealon (CAS 175175-23-2) - ORAL CAPSULE Form Only
1000 PCS Feb 4, 2026
United States
Epitalon & Pinealon Peptides - Oral Capsule Form
10 G Feb 3, 2026
United States
Epithalon
10 Jan 6, 2026
United States
Epitalon
2 G Jan 6, 2026
United States
Epitalon
5 MT Jul 19, 2025
United States
Epithalon
10 MT Apr 2, 2025
South Korea
epitalon
1 G Feb 22, 2025 Post an enquiry for this product